"Stierli Investor Relations has brought Novell important associations with the leading institutional investors across the financial markets of Europe.

The personal respect with which Julia Stierli is held by the "real clients" - the investors - has enabled Novell to better fulfill its commitment to engage and support European shareholders."

Dick Levy, President & CEO, Varian Medical Inc:

"Julia Stierli has worked with Varian Associates Inc. for many years and with the newly formed Varian Medical Systems in the last year. She contacted high quality potential investors on behalf of the company and organized social and business events with a high degree of efficiency and professionalism and did so at reasonable cost to the company. I can recommend her services without reservation."

Stephen A. Sherwin, M.D., Chairman and Chief Executive Officer, Cell Genesys Inc:
"Julia Stierli is well connected with the investment community in Europe and recently arranged a well organized and well attended investor roadshow for Cell Genesys which spanned four countries. We look forward to utilizing Stierli Investor Relations for future European investor meetings."

Lev Leytes, CEO, LJL Biosystems Inc:

"Julia Stierli has worked with LJL BioSystems for the past couple of years. She successfullly arranged many investor meetings and press interviews throughout Europe. We would be happy to serve as a reference."

LJL Biosystems acquired by Molecular Devices Corporation

Brian M. Hearst, CA, Chief Financial Officer, Canoro Resources Ltd.:

"Stierli Investor Relations skilfully handled all the detailed arrangements for the Company to meet with an extensive group of very high-level investment professionals.  The excellent venue, facilities, services, and refreshments showcased the Company and its investor presentations superbly.  I very strongly recommend this firm for top quality investor relations services